LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1,444 Cr | ₹1,193 Cr | ₹1,159 Cr | ₹1,179 Cr | ₹928 Cr |
What is the latest Total Non-Current Liabilities ratio of LAURUS LABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹1,444 Cr |
| Mar2025 | ₹1,193 Cr |
| Mar2024 | ₹1,159 Cr |
| Mar2023 | ₹1,179 Cr |
| Mar2022 | ₹928 Cr |
How is Total Non-Current Liabilities of LAURUS LABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,444 Cr | 21.04 | |
| Mar2025 | ₹1,193 Cr | 2.95 | |
| Mar2024 | ₹1,159 Cr | -1.72 | |
| Mar2023 | ₹1,179 Cr | 27.10 | |
| Mar2022 | ₹928 Cr | - | |
Compare Total Non-Current Liabilities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹110,977.6 Cr | 3.4% | 9.7% | 133.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -5.4% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,390.0 Cr | 0.7% | 3.2% | 61.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.8% | -3% | 32.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -2.9% | -3.3% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -3.3% | 4.7% | -2.2% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 3.4% |
9.7% |
133.5% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses